Aggregation of the Protein TRIOBP-1 and its potential relevance to schizophrenia

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Bradshaw, Nicholas J ^a   Bader, Verian ^a   Prikulis, Ingrid ^a   Lueking, Angelika ^b   Müllner, Stefan ^b   Korth, Carsten ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b PROTAGEN AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; ACTIN; ACTIN BINDING PROTEIN; PROTEIN AGGREGATE; RNA SPLICING; SYNAPSIN; TRIOBP PROTEIN, HUMAN;

ACTIN FILAMENT; ANTIBODY SPECIFICITY; ARTICLE; CELL INTERACTION; CLINICAL ARTICLE; COILED BODY; CONTROLLED STUDY; GENE; GENE LOCUS; GENE OVEREXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE CELL; NEUROBLASTOMA CELL; NEUROSCREEN 1 CELL; PROTEIN AGGREGATION; SCHIZOPHRENIA; TRIOBP1 GENE; TRIOBP4 GENE; TRIOBP5 GENE; AUTOPSY; BRAIN; CELL DIFFERENTIATION; CULTURE TECHNIQUE; GENETICS; IMMUNOLOGY; METABOLISM; NEURITE; PATHOLOGY; PROTEINOSIS; RNA SPLICING;

ACTINS; ANTIBODIES, MONOCLONAL; AUTOPSY; BRAIN; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; EPITOPES; HUMANS; MICROFILAMENT PROTEINS; NEURITES; NEURONS; PROTEIN AGGREGATES; PROTEIN AGGREGATION, PATHOLOGICAL; RNA SPLICE SITES; SCHIZOPHRENIA; SYNAPSINS;

EID: 84908181107     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111196     Document Type: Article

References (51)

1. Kendler KS (2013) What psychiatric genetics has taught us about the nature of psychiatric illness and what is left to learn. Mol Psychiatry 18: 1058-1066.
2. Cavallucci V, D'Amelio M, Cecconi F. (2012) Ab Toxicity in Alzheimer's Disease. Molecular Neurobiology 45: 366-378.
3. Bertram L, Lill CM, Tanzi R.E. (2010) The Genetics of Alzheimer Disease: Back to the Future. Neuron 68: 270-281.
4. Korth C (2012) Aggregated proteins in schizophrenia and other chronic mental diseases: DISC1opathies. Prion 6: 134-141.
5. Leliveld SR, Bader V, Hendriks P., Prikulis I, Sajnani G, et al (2008) Insolubility of Disrupted-in-Schizophrenia 1 disrupts oligomer-dependent interactions with Nuclear Distribution Element 1 and is associated with sporadic mental disease. J Neurosci 28: 3839-3845.
6. Ottis P, Bader V, Trossbach S.V., Kretzschmar H., Michel M, et al. (2011) Convergence of two independent mental disease genes on the protein level: Recruitment of dysbindin to cell-invasive Disrupted-in-Schizophrenia 1 aggre-somes. Biol Psychiatry 70: 604-610.
7. Bader V, Tomppo L, Trossbach S.V., Bradshaw NJ, Prikulis I, et al. (2012) Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits. Hum Mol Genet 21: 4406-4418.
8. Ottis P, Topic B, Loos M., Li KW, de Souza Silva MA, et al. (2013) Aging-induced proteostatic changes in the rat hippocampus identify ARP3, NEB2 and BRAG2 as a molecular circuitry for cognitive impairment PLoS ONE 8: e75112.
9. Seipel K, O'Brien SP, Iannotti E, Medley Q.G., Streuli M. (2001) Tara, a novel F-actin binding protein, associates with the Trio guanine nucleotide exchange factor and regulates actin cytoskeletal organization. J Cell Sci 114: 389-399.
10. Riazuddin S, Khan SN, Ahmed Z.M., Ghosh M., Caution K, et al. (2006) Mutations in TRIOBP, which encodes a putative cytoskeletal-organizing protein, are associated with nonsyndromic recessive deafness. Am J Hum Genet 78: 137-143.
11. Bao J, Bielski E, Bachhawat A., Taha D, Gunther LK, et al (2013) R1 motif is the major actin-binding domain of TRIOBP-4. Biochemistry 52: 5256-5264.
12. Yano T, Yamazaki Y, Adachi M., Okawa K, Fort P, et al (2011) Tara up-regulates E-cadherin transcription by binding to the Trio RhoGEF and inhibiting Rac signaling. J Cell Biol 193: 319-332.
13. 2-induced human mesenchymal stem cells migration and proliferation. J Cell Physiol 226: 559-571.
14. Lee YJ, Kim MO, Ryu J.M., Han H.J. (2012) Regulation of SGLT expression and localization through Epac/PKA-dependent caveolin-1 and F-actin activation in renal proximal tubule cells. Biochim Biophys Acta 1823: 971-982.
15. Shahin H, Walsh T, Sobe T., Abu Sa'ed J, Abu Rayan A, et al. (2006) Mutations in a novel isoform of TRIOBP that encodes a filamentous-actin binding protein are responsible for DFNB28 recessive nonsyndromic hearing loss. Am J Hum Genet 78: 144-152.
16. Diaz-Horta O., Duman D, Foster J., Sirmaci A, Gonzalez M, et al (2012) Whole-exome sequencing efficiently detects rare mutations in autosomal recessive nonsyndromic hearing loss. PLOS One 7: e50628.
17. Gu X, Guo L, Ji H., Sun S, Chai R, et al (2014) Genetic testing for sporadic hearing loss using targeted massively parallel sequencing identifies 10 novel mutations. Clin Genet doi:10.1111/cge.12431.
18. Kitajiri S-i, Sakamoto T., Belyantseva IA, Goodyear RJ, Stepanyan R, et al (2010) Actin-bundling protein TRIOBP forms resilient rootlets of hair cell stereocilia essential for hearing. Cell 141: 786-798.
19. Hennah W, Porteous D. (2009) The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genes. PLoS One 4: e4906.
20. Hennah W, Tomppo L, Hiekkalinna T., Palo OM, Kilpinen H, et al. (2007) Families with the risk allele of DISC1 reveal a link between schizophrenia and another component of the same molecular pathway, NDE1. Hum Mol Genet 6: 453-462.
21. Bradshaw NJ, Hennah W, Soares D.C. (2013) NDE1 and NDEL1: twin neurodevelopmental proteins with similar 'nature' but different 'nurture'. Biomol Concepts 4: 447-464.
22. Campeau E, Ruhl VE, Rodier F, Smith C.L., Rahmberg BL, et al. (2009) A versatile viral system for expression and depletion of proteins in mammalian cells. PLOS One 4: e6529.
23. Ard MD, Goldstein MN, Nash D.R., Gottlieb D.I. (1985) NMB: A human neuroblastoma cell line with specific opiate binding sites. Biochem Biophys Res Commun 133: 60-66.
24. Biedler JL, Roffler-Tarlov S, Schachner M., Freedman L.S. (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38: 3751-3757.
25. Zheng L, Zheng J, Whitlon D.S., García-Añoveros J, Bartles JR (2010) Targeting of the hair cell proteins cadherin 23, harmonin, myosin XVa, espin, and prestin in an epithelial cell model. J Neurosci 30: 7187-7201.
26. Presgraves SP, Ahmed T, Borwege S., Joyce J.N. (2004) Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox Res 5: 579-598.
27. Porat S, Simantov R. (1999) Bcl-2 and p53: Role in dopamine-induced apoptosis and differentiation. Ann N Y Acad Sci 893: 372-375.
28. Lueking A, Beator J, Patz E., Müllner S, Mehes G., et al. (2008) Determination and validation of off-target activities of anti-CD44 variant 6 antibodies using protein biochips and tissue microarrays. Biotechniques 45: Pi-Pv.
29. Conchillo-Solé O, de Groot NS, Avilés FX, Vendrell J, Daura X, et al. (2007) AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics 8: 65.
30. Garbuzynskiy SO, Lobanov MY, Galzitskaya O.V. (2010) FoldAmyloid: a method of prediction of amyloidogenic regions from protein sequence. Bioinformatics 26: 326-332.
31. Fang Y, Gao S, Tai D., Middaugh CR, Fang J. (2013) Identification of properties important to protein aggregation using feature selection. BMC Bioinformatics 14: 314.
32. Fernandez-Escamilla A-M, Rousseau F, Schymkowitz J, Serrano L (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotech 22: 1302-1306.
33. Linding R, Schymkowitz J, Rousseau F., Diella F, Serrano L. (2004) A comparative study of the relationship between protein structure and β-aggregation in globular and intrinsically disordered proteins. J Mol Biol 342: 345-353.
34. Rousseau F, Schymkowitz J, Serrano L. (2006) Protein aggregation and amyloidosis: Confusion of the kinds? Curr Opin Struct Biol 16: 118-126.
35. McGuffin LJ, Bryson K, Jones D.T. (2000) The PSIPRED protein structure prediction server. Bioinformatics 16: 404-405.
36. Lupas A, Van Dyke M, Stock J. (1991) Predicting coiled-coils from protein sequences. Science 252: 1162-1164.
37. Ishida T, Kinoshita K. (2008) Prediction of disordered regions in proteins based on the meta approach. Bioinformatics 24: 1344-1348.
38. Obenauer JC, Cantley LC, Yaffe M.B. (2003) Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 31: 3636-3641.
39. Leliveld SR, Hendriks P, Michel M., Sajnani G, Bader V, et al (2009) Oligomer assembly of the C-terminal DISC1 domain (640-854) is controlled by self-association motifs and disease-associated polymorphism S704C. Biochemistry 48: 7746-7755.
40. Bradshaw NJ, Soares DC, Carlyle B.C., Ogawa F., Davidson-Smith H, et al. (2011) PKA phosphorylation of NDE1 is DISC1/PDE4 dependent and modulates its interaction with LIS1 and NDEL1. J Neurosci 31: 9043-9054.
41. Torrey EF, Webster M, Knable M., Johnston N, Yolken R.H. (2000) The Stanley Foundation brain collection and Neuropathology Consortium. Schizophr Res 44: 151-155.
42. Kent WJ, Sugnet CW, Furey T.S., Roskin KM, Pringle TH, et al. (2002) The Human Genome Browser at UCSC. Genome Res 12: 996-1006.
43. Atkin TA, Brandon NJ, Kittler J.T. (2012) Disrupted in Schizophrenia 1 forms pathological aggresomes that disrupt its function in intracellular transport. Hum Mol Genet 21: 2017-2028.
44. Als TD, Dahl HA, Flint T.J., Wang AG, Vang M, et al. (2004) Possible evidence for a common risk locus for bipolar affective disorder and schizophrenia on chromosome 4p16 in patients from the Faroe Islands. Mol Psychiatry 9: 93-98.
45. Itokawa M, Kasuga T, Yoshikawa T., Matsushita M. (2004) Identification of a male schizophrenic patient carrying a de novo balanced translocation, t(4; 13)(p16.1; q21.31). Psychiatry and Clin Neurosci 58: 333-337.
46. Yerabham ASK, Weiergräber OH, Bradshaw N.J., Korth C. (2013) Revisiting Disrupted in Schizophrenia 1 as a scaffold protein. Biol Chem 394: 1425-1437.
47. David A, Malmberg A, Lewis G., Brandt L, Allebeck P. (1995) Are there neurological and sensory risk factors for schizophrenia? Schizophr Res 14: 247-251.
48. Moreno C, Nuevo R, Chatterji S., Verdes E, Arango C, et al (2013) Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey. World Psychiatry 12: 251-257.
49. Fors A, Abel KM, Wicks S, Magnusson C., Dalman C. (2013) Hearing and speech impairment at age 4 and risk of later non-affective psychosis. Psychol Med 43: 2067-2076.
50. Truyers C, Buntinx F, De Lepeleire J, De Hert M, Van Winkel R, et al. (2011) Incident somatic comorbidity after psychosis: Results from a retrospective cohort study based on Flemish general practice data. BMC Fam Pract 12: 132.
51. Knight HM, Maclean A, Irfan M., Naeem F, Cass S, et al (2008) Homozygosity mapping in a family presenting with schizophrenia, epilepsy and hearing impairment. Eur J Hum Genet 16: 750-758.